Breaking News

Empathy, a measles update, & a farewell

April 12, 2024
Reporter, Morning Rounds Writer
Good morning. I recommend a First Opinion on the role that design plays in medical procedures and devices. And I encourage you to read to the end of this newsletter, where I have some news of my own.

health tech

Monument banned by FTC for sharing patient health data with advertisers

AP23354714103105

Adobe

The FTC showed it's as good as its word to crack down on digital health companies playing fast and loose with personal health data. Yesterday, the agency took action against Monument, an alcohol addiction telehealth company that the FTC alleged revealed health information to third parties, including Meta and Google, without users' consent. The action followed a joint investigation by STAT and The Markup.

Monument was one of dozens of telehealth companies leaking sensitive health data through third-party trackers used to trail users across the internet and target advertising, the investigation showed. Yesterday's digital health enforcement is one of a series of actions that began last February, when the FTC implemented its long-dormant Health Breach Notification Rule against GoodRx. "The market should be getting the message that consumer health data should be handled with extreme caution," said Samuel Levine, director of the FTC's Bureau of Consumer Protection, in a release. STAT's Katie Palmer tells us more.


practice of medicine

Patients who feel the most empathy from their doctors report less low back pain, study says

Empathy patients feel from physicians surely forms a pleasant connection, but a new study in JAMA Network Open says the impact can be greater, easing the common and sometimes intractable problem of low back pain. Researchers found that over 12 months, people who called their physicians "very empathetic" said they had better outcomes than patients who got treatment from "slightly empathetic" physicians. The measures were pain, function, and health-related quality of life.

Levels of improvement among the patients reporting the most empathetic care were higher than for such treatments as exercise therapy, yoga, massage, spinal manipulation, acupuncture, and cognitive behavioral therapy as well as opioid therapy and lumbar spine surgery. "If we address only the biological aspect, by putting needles, doing the surgeries, … we might actually miss some opportunities to improve patient care," Shiqian Shen, a pain management physician at Massachusetts General Hospital, told STAT's Deborah Balthazar. Read more.


infectious disease

Where we stand on measles: Cases up, but 'elimination' status continues

The U.S. is holding steady on measles elimination, a new Centers for Disease Control and Prevention analysis says, although the growing number of cases recorded in the first quarter of the year could pose a threat. The status of the highly infectious disease has been "no longer constantly present" ever since 2000. That means measles is not spreading within the country, and new cases are found when someone contracts the virus abroad and brings it to the U.S.

Since January 2020, a total of 338 measles cases were reported to the CDC, 29% of them between January and March 2024. It's possible the Covid-19 pandemic kept the number of cases brought into the U.S. lower than when international  travel resumed, which could account for the recent jump in cases. CDC experts urge vaccination against measles, mumps, and rubella (the MMR series of shots for kids), especially among close-knit and undervaccinated communities.



closer look

Opinion: How women can improve reproductive justice and autonomy, by designAdobeStock_88942890

Adobe

The list of ways women suffer from suboptimal medical care is long, Catherine M. Klapperich tells us in a First Opinion, zeroing in on procedures and devices that were flawed from the start. A professor of biomedical engineering at Boston University, she catalogs the failures of the Dalkon Shield, the Essure sterilization device, morcellators, and the transvaginal mesh. When she was an engineering student in the 1990s, the prototypical human was a 154-pound man. In some ways, we're still there, she writes.

"If designers prioritized reducing the sexual, lifestyle, and mood side effects of hormonal contraceptives and the short-term pain of IUD insertion, women would have better options that would find wider use," she says. "Designers with no lived experience of gynecological pain, the anxieties of childbirth, or the stresses of avoiding pregnancy cannot properly assess the relative importance of these factors — especially when they do not even try." Read more.


health insurance

How Medicaid unwinding is unfolding

After Medicaid's pandemic-era continuous enrollment ended March 31, 2023, states were required to complete an eligibility renewal for all their Medicaid enrollees. This unwinding process is still affecting people who rely on Medicaid, the latest KFF enrollment tracker reports today. Its survey found that roughly one-fifth of people on Medicaid have been disenrolled while nearly half have been re-enrolled, with renewals for the rest still being processed. 

Disenrollment can happen when someone is no longer eligible for benefits or if the renewal process isn't completed; nearly 70% of people were disenrolled for so-called procedural reasons, while 30% were disenrolled because they were deemed ineligible. The survey contained limited data on children, but kids accounted for nearly 40% of disenrollments in the 17 states that broke down the results by age, ranging from 20% of disenrollments in Oregon to 65% in Texas.


farewell

Passing the Morning Rounds baton

So this is my last newsletter before I begin reporting on a new beat: cardiovascular and metabolic conditions. I'm excited to get started on this new challenge, but first, I'm thrilled to say the multitalented Theresa Gaffney — reporter, multimedia producer, and Monday newsletter author — will take over as lead Morning Rounds writer. 

It's been quite the ride for me for almost three years, starting when Covid-19 dominated our lives and the news, filling newsletters with stories distilled into 150-word items I composed from my home. Back in STAT's newsroom today, I am reminded of how much we needed each other: expert sources saying what we did and didn't know, reporters and editors making sense of it all, readers telling me what mattered to them most. 

It's been a privilege to point you to my STAT colleagues' authoritative, enlightening coverage, not just explaining the pandemic, but also exploring science, biotech, pharma, and policy. We've expanded to new coverage areas, from health tech to chronic diseases to health equity. You know what I mean: You read it every day.

One more thing: Some of you may recall I run marathons. When I started in August 2021, I said I was training for the Covid-delayed London and Boston races in the fall. Then I promptly sustained an injury that canceled London for me and saw me hobbling from Hopkinton to Boston.

Guess what's on my calendar for Monday. Not saying. 

Drop me a line with your thoughts on STAT, on cardiovascular and metabolic conditions, or on jinxes.


More around STAT
Check out more exclusive coverage with a STAT+ subscription
Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

What we're reading

  • Alone in a bathroom: Fear and uncertainty of a post-Roe medication abortion, Washington Post

  • This fMRI technique promised to transform brain research — why can no one replicate it? Nature

  • Opinion: Congress: Protect patients and enact the Nuclear Medicine Clarification Act, STAT
  • We shouldn't have to be willing to die to give birth in the U.S., TIME

  • Listen: Vertex's big deal, biotech's red numbers, & an industry history lesson, STAT

Thanks for reading! Theresa will have more Monday,


Enjoying Morning Rounds? Tell us about your experience
Continue reading the latest health & science news with the STAT app
Download on the App Store or get it on Google Play
STAT
STAT, 1 Exchange Place, Boston, MA
©2024, All Rights Reserved.

No comments